Search results
Results From The WOW.Com Content Network
The Vaccine Research Center (VRC), is an intramural division of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), US Department of Health and Human Services (HHS). The mission of the VRC is to discover and develop both vaccines and antibody-based products that target infectious ...
olpa.od.nih.gov: Office of Portfolio Analysis OPA OPA is an interdisciplinary team that impacts NIH-supported research by enabling NIH decision makers and research administrators to evaluate and prioritize current and emerging areas of research that will advance NIH's mission. OPA is housed within DPCPSI. dpcpsi.nih.gov /opa
The National Institutes of Health, Islamabad (NIH) (Urdu: قومی ادارہَ صحت), is a Pakistani research institute located in Islamabad, Pakistan. The institute is an autonomous body of Ministry of National Health Services, Regulation and Coordination , mainly responsible for biomedical and health related research along with vaccine ...
Previously, she was chief of the Biodefense Research Section at the Vaccine Research Center (VRC) in the National Institute of Allergy and Infectious Diseases (NIAID). [ 1 ] Sullivan was awarded the 2020 Science, Technology, and Environment Service to America Medal for the development of ansuvimab , an FDA-approved monoclonal antibody for the ...
John R. Mascola is an American physician-scientist, immunologist and infectious disease specialist. He was the director of the Vaccine Research Center [1] (VRC), part of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH).
This comprehensive vaccine and prevention program has led to a number of significant scientific advances in vaccine and prevention research. In the past, NIAID supported researchers have improved antigenicity through modifications to the envelope protein, elucidated the envelope structure of HIV, advanced our understanding of the role of ...
She joined Harvard following six years at the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIAID NIH) based in Bethesda, Maryland. [3] [4] She earned a PhD in microbiology and immunology from the University of North Carolina at Chapel Hill (UNC-Chapel Hill) in 2014. [5]
Community opposition to research at NEIDL, centered on concerns that the laboratory could expose the local population to dangerous pathogens, delayed work on BSL-2, BSL-3, and BSL-4 pathogens until 2012, 2014, and 2017, respectively. [3] [4] [5]